Costco & Sesame, Inbound Health +$30m, FDA guidance for Breakthrough Devices Program, Summus +$19.5m

11Likes

131Views

2023Oct 3

Unlock the latest breakthroughs in digital health with the September edition of Digital Health Digest! 🚀 Dive into a realm where technology meets healthcare, bringing you close to the recent advancements, collaborations, and regulatory updates that are shaping the future of health technology. Explore the details below and join us in navigating through the digital health landscape. 00:00 Introduction 00:09 Costco, Sesame partner to offer low-cost care to Costco members. The wholesaler's members can access virtual and in-person appointments through Sesame's platform. https://sesamecare.com/blog/sesame-co... 00:31 Inbound Health, a value-based care enablement platform for health systems and plans to provide at-home acute and post-acute care, announced the close of a $30 million Series B funding. https://www.inboundhealth.com/series-... 00:50 FDA releases updated final guidance for its Breakthrough Devices Program. The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process. https://www.fda.gov/medical-devices/m... 01:08 Virtual specialty care platform Summus announced it secured $19.5 million in funding, bringing its total raise to $70 million. Summus offers employers, health plans, hospitals and health systems, and medical groups and networks a virtual care platform focused on specialty care, including peer-to-peer solutions that allow primary care and in-plan specialist providers access to a specialist network. https://www.summusglobal.com/summus-r... Thank you for exploring the September highlights with Digital Health Digest! 🌟 Your monthly dose of digital health news and insights will be back soon - ensure you don't miss out by hitting that subscribe button.🔔 Like, share, and join the conversation in the comments below! See you in the next edition with more from the dynamic world of digital health.👋 Our August edition of the digest: • Babylon is in Trouble, Heart Failure E-cli... Don't forget to check out our latest Digital Health Interview with Yatin Patil: • Do Doctors Invest in Digital Health Startu... BeKey: https://bekey.io/healthcare-app-devel... #digitalheatlh #softwaredevelopment #hardwaredevelopment #medtech #wearables #hipaa #healthtech #standwithUkraine

Introduction

0:00

Costco, Sesame partner to offer low-cost care to Costco members.

0:09

Inbound Health, a value-based care enablement platform for health systems and plans to provide at-home acute and post-acute care, announced the close of a $30 million Series B funding.

0:31

FDA releases updated final guidance for its Breakthrough Devices Program. The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

0:50

Transcript

Follow along using the transcript.

Health2Tech

8.59K subscribers

Must-Have Regulations for Digital Health Startups: HIPAA, GDPR, ISO, FDA and more

by Health2Tech

Costco & Sesame, Inbound Health +$30m, FDA guidance for Breakthrough Devices Program, Summus +$19.5m

Chapters View all

Introduction

Introduction

Introduction

Costco, Sesame partner to offer low-cost care to Costco members.

Costco, Sesame partner to offer low-cost care to Costco members.

Costco, Sesame partner to offer low-cost care to Costco members.

Inbound Health, a value-based care enablement platform for health systems and plans to provide at-home acute and post-acute care, announced the close of a $30 million Series B funding.

Inbound Health, a value-based care enablement platform for health systems and plans to provide at-home acute and post-acute care, announced the close of a $30 million Series B funding.

Inbound Health, a value-based care enablement platform for health systems and plans to provide at-home acute and post-acute care, announced the close of a $30 million Series B funding.

FDA releases updated final guidance for its Breakthrough Devices Program. The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

FDA releases updated final guidance for its Breakthrough Devices Program. The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

FDA releases updated final guidance for its Breakthrough Devices Program. The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

Virtual specialty care platform Summus announced it secured $19.5 million in funding, bringing its total raise to $70 million.

Virtual specialty care platform Summus announced it secured $19.5 million in funding, bringing its total raise to $70 million.

Virtual specialty care platform Summus announced it secured $19.5 million in funding, bringing its total raise to $70 million.

Health2Tech

Costco & Sesame, Inbound Health +$30m, FDA guidance for Breakthrough Devices Program, Summus +$19.5m

Comments

Chapters

Introduction

Introduction

Introduction

Costco, Sesame partner to offer low-cost care to Costco members.

Costco, Sesame partner to offer low-cost care to Costco members.

Costco, Sesame partner to offer low-cost care to Costco members.

Inbound Health, a value-based care enablement platform for health systems and plans to provide at-home acute and post-acute care, announced the close of a $30 million Series B funding.

Inbound Health, a value-based care enablement platform for health systems and plans to provide at-home acute and post-acute care, announced the close of a $30 million Series B funding.

Inbound Health, a value-based care enablement platform for health systems and plans to provide at-home acute and post-acute care, announced the close of a $30 million Series B funding.

FDA releases updated final guidance for its Breakthrough Devices Program. The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

FDA releases updated final guidance for its Breakthrough Devices Program. The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

FDA releases updated final guidance for its Breakthrough Devices Program. The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

Virtual specialty care platform Summus announced it secured $19.5 million in funding, bringing its total raise to $70 million.

Virtual specialty care platform Summus announced it secured $19.5 million in funding, bringing its total raise to $70 million.

Virtual specialty care platform Summus announced it secured $19.5 million in funding, bringing its total raise to $70 million.

Description

Chapters View all

Introduction

Introduction

Introduction

Costco, Sesame partner to offer low-cost care to Costco members.

Costco, Sesame partner to offer low-cost care to Costco members.

Costco, Sesame partner to offer low-cost care to Costco members.

Inbound Health, a value-based care enablement platform for health systems and plans to provide at-home acute and post-acute care, announced the close of a $30 million Series B funding.

Inbound Health, a value-based care enablement platform for health systems and plans to provide at-home acute and post-acute care, announced the close of a $30 million Series B funding.

Inbound Health, a value-based care enablement platform for health systems and plans to provide at-home acute and post-acute care, announced the close of a $30 million Series B funding.

FDA releases updated final guidance for its Breakthrough Devices Program. The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

FDA releases updated final guidance for its Breakthrough Devices Program. The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

FDA releases updated final guidance for its Breakthrough Devices Program. The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

Health2Tech

Transcript

Chapters

Chapters